Citation Impact
Citing Papers
Effect of secretin on release of heterogeneous forms of gastrin.
1975 StandoutNobel
Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans
2001
Investigation of serotonin type 4 receptor expression in human and non-human primate gastrointestinal samples
2006
The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis
2018 Standout
Functional Bowel Disorders
2006 Standout
Honey, Propolis, and Royal Jelly: A Comprehensive Review of Their Biological Actions and Health Benefits
2017 Standout
Involvement of Cholecystokinin/Gastrin‐Related Peptides and their Receptors in Clinical Gastrointestinal Disorders
2002
The role of gastrointestinal vagal afferents in the control of food intake: current prospects
2000
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Functional Gastroduodenal Disorders
2006 Standout
Bowel Disorders
2016 Standout
Molecular, pharmacological and functional diversity of 5-HT receptors
2002 Standout
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome
2005
Anatomy and regulation of the central melanocortin system
2005 Standout
Gastrointestinal hormones and food intake
2005
Central nervous system control of food intake and body weight
2006 StandoutNature
Basic and clinical pharmacology of new motility promoting agents
2005
Modulation of Intestinal Gas Dynamics in Healthy Human Volunteers by the 5-HT4Receptor Agonist Tegaserod
2006
Emerging drugs for irritable bowel syndrome
2006
Glucoregulatory Relevance of Small Intestinal Nutrient Sensing in Physiology, Bariatric Surgery, and Pharmacology
2015
Obesity in menopause – our negligence or an unfortunate inevitability?
2017 Standout
Systematic Review on the Management of Chronic Constipation in North America
2005
Tegaserod, a 5‐HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects
2003
Central effects of estradiol in the regulation of food intake, body weight, and adiposity
2009
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
2008 Standout
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
Gut hormones in the control of appetite
2004
Role of cholecystokinin in appetite control and body weight regulation
2005
Pathophysiology and treatment of functional dyspepsia
2004
Physiological Modulation of Intestinal Motility by Enteric Dopaminergic Neurons and the D2Receptor: Analysis of Dopamine Receptor Expression, Location, Development, and Function in Wild-Type and Knock-Out Mice
2006
Neuroendocrine control of food intake
2008
Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation
2004
Upper intestinal lipids trigger a gut–brain–liver axis to regulate glucose production
2008 Nature
Characteristics of the Cholecystokinin-Induced Depolarization of Pacemaking Activity in Cultured Interstitial Cells of Cajal from Murine Small Intestine
2013 Standout
The Gut and Regulation of Body Weight
2004
CCK<sub>1</sub> Antagonists: Are They Ready for Clinical Use?
2006
Evidence of a Novel Quantitative-Trait Locus for Obesity on Chromosome 4p in Mexican Americans
2004
Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin
2011
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Cholecystokinin antagonists: Pharmacological and therapeutic potential
2003
Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes
2008 StandoutNobel
Irritable bowel syndrome
2016 Standout
Effects of lifestyle modification in polycystic ovarian syndrome
2006
Gut-Brain Cross-Talk in Metabolic Control
2017
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Effects of a 5‐HT4 receptor agonist on oesophageal function and gastro‐oesophageal reflux: studies using combined impedance‐manometry and combined impedance‐pH
2006
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Effect of tegaserod in chronic constipation: A randomized, double-blind, controlled trial
2004
Ileal brake: A sensible food target for appetite control. A review
2008
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The Timing of Meals.
2004
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Activation of peripheral 5‐HT4receptors attenuates colonic sensitivity to intraluminal distension
2005
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Structured emulsion-based delivery systems: Controlling the digestion and release of lipophilic food components
2010 Standout
Pharmacological management of appetite expression in obesity
2010
Gastrointestinal regulation of food intake
2007
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
MITEMCINAL (GM‐611), AN ORALLY ACTIVE MOTILIN RECEPTOR AGONIST, IMPROVES DELAYED GASTRIC EMPTYING IN A CANINE MODEL OF DIABETIC GASTROPARESIS
2008 StandoutNobel
The effects of tegaserod on oesophageal function and bolus transport in healthy volunteers: studies using concurrent high‐resolution manometry and videofluoroscopy
2006
Serotonin and GI clinical disorders
2008
Gut hormones: Implications for the treatment of obesity
2009
The role of hypothalamic estrogen receptors in metabolic regulation
2014
Regional gastric contractility alterations in a diabetic gastroparesis mouse model: effects of cholinergic and serotoninergic stimulation
2004
Tegaserod
2001
Influence of tegaserod on proximal gastric tone and on the perception of gastric distension
2003
Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour
2016
Dietary Lipids and Functional Gastrointestinal Disorders
2013
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
2003
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
2014
Appetite signaling: From gut peptides and enteric nerves to brain
2007
Guidelines on the irritable bowel syndrome: mechanisms and practical management
2007
Childhood Functional Gastrointestinal Disorders: Child/Adolescent
2006 Standout
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation
2002
Energy Metabolism in the Liver
2014 Standout
Stimulation of Cholecystokinin-A Receptors With GI181771X does not Cause Weight Loss in Overweight or Obese Patients
2007
Management of Chronic Constipation in the Elderly
2008
Gastrointestinal targets of appetite regulation in humans
2010
Ghrelin: Structure and Function
2005 Standout
Intestinal Cholecystokinin Controls Glucose Production through a Neuronal Network
2009
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
2008 Standout
Effect of tegaserod on gut transit in male and female subjects
2005
Food-Grade Nanoemulsions: Formulation, Fabrication, Properties, Performance, Biological Fate, and Potential Toxicity
2011 Standout
Functional dyspepsia: evaluation and treatment
2003
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Oil and Tocopherol Content and Composition of Pumpkin Seed Oil in 12 Cultivars
2007 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis
2004
Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.
1998 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Genotype × Environment Interactions and Heritability of Tocopherol Contents in Canola
2004
Evaluation of the Effect of Enteral Lipid Sensing on Endogenous Glucose Production in Humans
2015
The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis
2013
The effects of somatostatin and metiamide on tachyphylaxis of pentagastrin stimulated gastric acid and pepsin secretion in the conscious cat.
1977 StandoutNobel
Effect of Tegaserod on Esophageal Pain Threshold, Regurgitation, and Symptom Relief in Patients With Functional Heartburn and Mechanical Sensitivity
2006
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Relating Food Emulsion Structure and Composition to the Way It Is Processed in the Gastrointestinal Tract and Physiological Responses: What Are the Opportunities?
2010
Obesity: global epidemiology and pathogenesis
2019 Standout
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Works of Daniel Matzinger being referenced
Role of Free Fatty Acids in Regulating Gastric Emptying and Gallbladder Contraction
2006
Tegaserod, a 5‐HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects
2001
Effects of a Preload on Reduction of Food Intake by GLP-1 in Healthy Subjects
2006
The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans
2000
The effect of cholecystokinin in controlling appetite and food intake in humans
2001
Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men
2004
Tegaseroid (HTF 919), a partial 5-HT4 receptor agonist, accelerates gastrointestinal (GI) transit
2000
Tocopherole – Antioxidantien der Natur
1995
Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans
2001
Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans
1999